secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001753926-26-000315
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q4 2025 revenue $4.9M, net loss $3.2M; CMS code boost effective Jan 2026
--------------------------------------------------------------------------------

- Q4 revenue $4.9M, down from $13.1M YoY; net loss $3.2M ($0.19/sh) vs net income $1.5M ($0.09/sh) in Q4 2024.
- Shipped 14 SRT systems in Q4 (8 US, 6 international), up from 6 in Q3 excluding largest customer.
- Ended 2025 with $22.1M cash and no debt; full-year revenue $27.5M, net loss $7.7M.
- CMS published dedicated CPT codes for SRT effective Jan 1, 2026, providing 300% per-fraction increase and reimbursement certainty.
- Expects sequential revenue growth in Q1 2026 and full-year profitability; FDA program delivered 11,411 treatments (+8x YoY).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000175392626000315/0001753926-26-000315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000175392626000315/g085130_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-000315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer